Australian microbiome testing company Microba Life Sciences (ASX:MAP) has signed agreements with SYNLAB affiliates in Poland, Hungary, Romania, and Croatia to distribute Microba's testing technology in the countries.

Microba Life Sciences says the deal expands the partnership between the health tech company and Europe's largest medical diagnostics company.

Microba and SYNLAB have entered a series of agreements since 2020, focusing on European distribution and catering to healthcare providers in 36 countries.

Successful expansions include Microba's testing technology distribution in Italy, Portugal, Turkey, and the Czech Republic.